Clinical Trial Update: Sonidegib in Adult Patients With Locally Advanced Basal Cell Carcinoma (laBCC) in China [Phase 4]

View source ↗

Summary

Phase 4 clinical trial in China evaluating Sonidegib for locally advanced basal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Sonidegib (Sonidegib)

Snippet

Sponsor: Jemincare | Conditions: Carcinoma, Basal Cell (BCC) | Phase 4 | Status: COMPLETED